跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Clavexin
Approved
STANDARD
Clavexin
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
79bb5f9a64ef8765
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
79bb5f9a64ef8765
Drug Approval Philippines Name
Clavexin
Product Name
Clavexin
Registration Number
DRP-293-03
Brand Name
Clavexin
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Suspension
Dosage Strength
125 mg/31.25 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Gamot Philippines, Inc.
Distributor
D.B. Manix International, Inc.
Issuance Date
25 April 2022
Expiry Date
12 September 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
79bb5f9a64ef8765
Type
Standard
Back to Philippines FDA Approvals
Clavexin - Philippines FDA Drug Approval Details